Bildkälla: Stockfoto

Vicore Pharma: Our Q2 Comment - Redeye

Redeye comments on yesterday’s Q2 report from Vicore, which came in as expected.

Redeye comments on yesterday’s Q2 report from Vicore, which came in as expected.
Börsvärldens nyhetsbrev
ANNONSER